Researchers launch study on Ebola treatments as Congo outbreak worsens

Researchers in Congo have initiated a study to test two potential Ebola treatments, remdesivir and MBP134, amid a worsening outbreak caused by the Bundibugyo virus. The World Health Organization reported over 1,400 cases and 438 deaths, with the trial aiming to determine if the drugs improve survival rates. The study, conducted in collaboration with multiple international institutions, faces challenges due to violence in the region.